7–10 Sept 2016
Laboratori Nazionali del Sud of INFN
Europe/Rome timezone

Session

Radiation Biology and Medical Applications

8 Sept 2016, 09:00
Conference Hall (Laboratori Nazionali del Sud of INFN)

Conference Hall

Laboratori Nazionali del Sud of INFN

Via S. Sofia 62, 95123 Catania Italy

Conveners

Radiation Biology and Medical Applications: I

  • Satyabrata Kar (Queen's University Belfast)

Radiation Biology and Medical Applications: II

  • Stephan Kraft (Helmholtz-Zentrum Dresden-Rossendorf)

Presentation materials

There are no materials yet.

  1. Prof. Yann Gauduel (LOA Ecole Polytechnique - ENSTA)
    08/09/2016, 09:00
    Invited Review
    It is generally admitted that an initial spatial distribution of energy deposition following the interaction of ionising radiations (UV and X rays, electron, proton and accelerated ions) with living matter (molecular targets or integrated biological systems) is decisive for the behaviour and control of radiation effects that take place on several orders of magnitude. The complex links that...
    Go to contribution page
  2. Prof. Pawel Olko (Institute of Nuclear Physics PAN)
    08/09/2016, 09:40
    Invited
    In the last decade significant technological progress lead to the real boom in the proton therapy The major progress was observed in introduction of the active Pencil Beam Scanning (PBS) and construction of dedicated medical proton accelerators. The PBS technique allows to irradiate target volume spot-by-spot, without any mechanical collimation, leads to further reduction of the entrance...
    Go to contribution page
  3. Dr K. Hideghety (ELI-ALPS)
    08/09/2016, 10:05
    Invited
    There has been a vast development of laser driven particle acceleration (LDPA) using high power lasers. This has driven by the radiation oncology community to use the dose distribution and biological advantages of proton/heavy ion therapy in cancer treatment with a much greater accessibilty than currently possible with cyclotron/synchrotron acceleration. Up to now, preclinical experiments have...
    Go to contribution page
  4. Dr Dana Niculae (IFIN-HH)
    08/09/2016, 10:30
    Oral contribution
    Radioisotopes applications in nuclear medicine are in the field of both diagnosis (oncology, cardiology and neurology) and therapy (oncology). Molecular imaging probes, a special class of radiopharmaceuticals, targets specific biochemical signatures associated with disease and allow for non-invasive imaging on the molecular level. Because changes in biochemistry occur before diseases reach the...
    Go to contribution page
  5. Lorenzo Manti (INFN Section of Naples)
    08/09/2016, 11:10
    Invited Review
    Proton-based radiotherapy has become an increasingly common cancer treatment modality. The clinical exploitation of accelerated protons relies on their superior ballistic properties compared to photons, which translates in advantageous dose distribution to tumor and sparing of normal tissue. The need for cost and size reduction of particle accelerating machines, which would arguably benefit...
    Go to contribution page
  6. Mr Loann Pommarel (Laboratoire d'Optique Appliquée, ENSTA ParisTech / CNRS / École polytechnique, Université Paris-Saclay)
    08/09/2016, 11:50
    Oral contribution
    Proton acceleration by laser-plasma interaction is gaining scientific interest thanks to recent developments in laser technology. Laser-produced ion beams are reliable enough to envision multiple applications, such as experiments of dose deposition into living cells. The study of radiation biology on laser based accelerators is most interesting due to the unique irradiation conditions (high...
    Go to contribution page
  7. Dr Luigi Minafra (IBFM CNR)
    08/09/2016, 12:10
    Oral contribution
    First radiobiological experience at ILIL with electron beams generated by a 2TW laser system.
    Go to contribution page
Building timetable...